<DOC>
	<DOCNO>NCT00214136</DOCNO>
	<brief_summary>The purpose study examine clinical feasibility efficacy uing IMRT escalate biologically effective dose pelvic lymph node short course radiation therapy . An increased total biologically effective dose deliver pelvic lymph node ( 56 Gy 2 Gy/fraction ) . The prostate receive standard `` short course '' IMRT radiation ( 70 Gy 2.5 Gy/fraction ) .</brief_summary>
	<brief_title>Intensity Modulated Radiation Therapy ( IMRT ) Radiotherapy Treating Prostate Pelvic Nodes</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate cancer stage TT3 Predicted risk lymph node involvement &gt; 15 % Gleason &gt; 7 Distance metastasis Use anticoagulant therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>